Ovide-Henri Bernadotte
Child & Adolescent Psychiatry · Clewiston, FLNPI 1598777294
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 497 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,023, 7.5 times the $271 reported in 2019. Among child & adolescent psychiatry clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 497 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$2K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$830
- Neurocrine Biosciences, Inc.$783
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$718
- Johnson & Johnson$567
- plus $2K from 17 others
What the payments were for
- Food & beverage$8,049100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 156 | $1,593 |
| AbbVie(2 entities) | 58 | $1,097 |
| Otsuka America Pharmaceutical, Inc. | 37 | $830 |
| Neurocrine Biosciences, Inc. | 36 | $783 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 44 | $718 |
| Johnson & Johnson | 28 | $567 |
| Teva Pharmaceuticals USA, Inc. | 29 | $415 |
| Alkermes, Inc. | 19 | $403 |
| Ironshore Pharmaceuticals Inc. | 14 | $220 |
| E.r. Squibb & Sons, L.L.C. | 12 | $209 |
| Collegium Pharmaceutical, Inc. | 6 | $198 |
| Vanda Pharmaceuticals Inc. | 8 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $137 |
| Lundbeck LLC | 8 | $136 |
| Indivior Inc. | 6 | $130 |
| Tris Pharma Inc | 7 | $127 |
| Corium, LLC | 4 | $68 |
| Noven Therapeutics, LLC | 3 | $58 |
| Shire North American Group Inc | 3 | $57 |
| Adlon Therapeutics L.p. | 4 | $51 |
| Sunovion Pharmaceuticals Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JORNAY PM$125
How this compares
$8,062 in reported general payments places this provider in the 90th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Other child & adolescent psychiatry in Clewiston
- Craig KuninsGulfport$265K
- Elias SarkisGainesville$169K
- Jeffrey AlvaroSt Petersburg$87K
- Rosa Negron MunozLakeland$39K
- Sean HoranMiami$17K
- Rachel AgustinesLargo$16K
- Carlos BorgeSarasota$15K
- Justin SpoonerPonte Vedra Beach$12K
- Bhaskar RajuOrlando$11K
- Americo PadillaMiami$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.